Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01030276 |
Date of registration:
|
10/12/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Bright Light Therapy in Seasonal Affective Disorder (SAD)
VAHAVA |
Scientific title:
|
Placebo-controlled, Double Blind RCT on the Efficacy of Bright Light Therapy in SAD |
Date of first enrolment:
|
October 2009 |
Target sample size:
|
60 |
Recruitment status: |
Recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT01030276 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Finland
| | | | | | | |
Contacts
|
Name:
|
Markku J Timonen, Prof |
Address:
|
|
Telephone:
|
+358 40 8324883 |
Email:
|
markku.timonen@oulu.fi |
Affiliation:
|
|
|
Name:
|
Markku J Timonen, Prof |
Address:
|
|
Telephone:
|
+ 358 40 8324883 |
Email:
|
markku.timonen@oulu.fi |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- a patient has, according to the DSM-IV-TR, a Major depression, recurrent episode,
seasonal pattern, "moderate" or "severe" (classification code 296.32 and 296.33)
- HAMD-21 (included in the SIGH-SAD) sum score is = 22
- patient is over 18 years
- patient can read and understand the subject information sheet
- patient has signed the informed consent form
- patient is not pregnant
Exclusion Criteria:
- patient has a lifetime psychotic disorder
- patient has a DSM-IV Axis I disorder other than some anxiety disorder evaluated by
MINI
- patient has some DSM-IV-TR Axis II disorder, which is likely to interfere with the
study treatment according to the investigator
- patient has alcohol or some other substance use dependence or misuse
- life-time suicide attempt, or any thought of suicide during the last month
- patients has some unstable somatic disorder
- patient uses some medication on regular basis
- patient uses some herbal psychotropic agencies
- patient is, in the opinion of the investigator, unsuitable for any reason
- patient is a member of the site personnel or their immediate families
- patient has had bright light therapy during the current episode
- patient has some eye disease (patient can, however, be myopic or hyperopic)
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Seasonal Affective Disorder
|
Intervention(s)
|
Other: Bright light therapy
|
Other: Inactive "placebo-light"
|
Primary Outcome(s)
|
Remission as defined by the SIGH-SAD
[Time Frame: 28 (visit window from 26 to 30 days) days after the inclusion day]
|
Secondary Outcome(s)
|
Decrease of the severity of symptoms as assessed by SIGH-SAD, Hamilton anxiety scale, and Beck depression inventory-21
[Time Frame: 28 (visit window from 26 to 30 days) days]
|
Secondary ID(s)
|
FI (FWA00000190) 11/2008
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|